Robert M. Strieter, M.D.

Robert M. Strieter, MD

Strieter Consulting
Email verificata su virginia.edu
Citato da 103719
Early drug development Immunology Inflammation Fibrosis Angiogenesis
Heinz-Josef Lenz

Heinz-Josef Lenz

University of Southern Califfornia
Email verificata su usc.edu
Citato da 88094
GI Oncology Molecular Characterization Early Drug Development colon cancer oncology
Thomas Hutson

Thomas Hutson

TTUHSC School of Medicine/UMC Cancer Center Director
Email verificata su ttuhsc.edu
Citato da 59917
Oncology Urologic Cancers Early Drug Development
David M Hyman

David M Hyman

Loxo Oncology, Eli Lilly
Email verificata su loxooncology.com
Citato da 43843
Oncology Precision Medicine Cancer Genomics Developmental Therapeutics Early Drug Development
Alexia Iasonos

Alexia Iasonos

Memorial Sloan Kettering Cancer Center
Email verificata su mskcc.org
Citato da 15286
biostatistics clinical trials early drug development
Swaminathan Padmanabhan Iyer

Swaminathan Padmanabhan Iyer

Professor of Medicine, University of Texas MD Anderson Cancer Center
Email verificata su mdanderson.org
Citato da 12594
Lymphoma Myeloma Early Drug Development
Glenn J. Hanna, M.D.

Glenn J. Hanna, MD

Associate Professor of Medicine, Harvard Medical School
Email verificata su dfci.harvard.edu
Citato da 5600
Head and Neck Oncology Early Drug Development
Adam J. Schoenfeld

Adam J. Schoenfeld

Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center,
Email verificata su mskcc.org
Citato da 5202
Thoracic oncology Cellular Therapy Immunotherapy Early drug development
Raymond P Perez

Raymond P Perez

Email verificata su kumc.edu
Citato da 4842
Cancer early drug development phase I
Paolo Tarantino

Paolo Tarantino

Dana-Farber Cancer Institute, Harvard Medical School
Email verificata su dfci.harvard.edu
Citato da 3715
Breast Cancer Early Drug Development HER2 Antibody-Drug Conjugates Immunotherapy
1 - 10